APA (7th ed.) Citation

B, Q., HA, L., XF, X., JJ, Y., YP, W., HT, Z., . . . VKW, W. (2026). Alleviation of osteoarthritis progression through far-infrared therapy targeting osteoclast cytoskeleton and MAPK/c-Fos/NFATc1 signaling inhibition. Pharmacological research, 228, 108221. https://doi.org/10.1016/j.phrs.2026.108221

Chicago Style (17th ed.) Citation

B, Qin, et al. "Alleviation of Osteoarthritis Progression Through Far-infrared Therapy Targeting Osteoclast Cytoskeleton and MAPK/c-Fos/NFATc1 Signaling Inhibition." Pharmacological Research 228 (2026): 108221. https://doi.org/10.1016/j.phrs.2026.108221.

MLA (9th ed.) Citation

B, Qin, et al. "Alleviation of Osteoarthritis Progression Through Far-infrared Therapy Targeting Osteoclast Cytoskeleton and MAPK/c-Fos/NFATc1 Signaling Inhibition." Pharmacological Research, vol. 228, 2026, p. 108221, https://doi.org/10.1016/j.phrs.2026.108221.